Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas

Pathology Research and Practice

Volumn 200, Issue 1, 2004, Pages 13-23

  Matheus, Roberto Storte ^a   Del Carlo Bernardi, Fabíola ^b   Gallo, Célia Petrossi ^b   da Silva, Alecsander Pereira ^b   Rodrigues, Olavo Ribeiro ^a   Capelozzi, Marisa ^b   Lopes, Ademar ^c   Fenezelian, Sandra ^b   Nascimento Saldiva, Paulo Hilário ^b   Capelozzi, Vera Luiza ^b  

^a UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Department of Pelvic Surgery AC Camargo ^*  (Brazil)

Author keywords

AgNOR; Ki 67; Lung cancer; Mitotic index; Morphometry; Star volume

Indexed keywords

CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN P27;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH RATE; HISTOCHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; MITOSIS INDEX; MORPHOMETRICS; SURVIVAL TIME;

EID: 3242734788     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2003.12.007     Document Type: Article

References (35)

1. Abe S. Isobe H. Ogura S. Nakajima I. Watanabe N. Sukoh N. Takekawa H.Y. Kunikani H. Kawakami Y. Nucleolar organiser regions, nucleolar DNA content, and proliferative activity in adenocarcinoma of the lung Nippon Kyobu Shikkan Gakkai Zasshi 29 1991 1282-1286
2. Antonangelo L. Bernardi F.D.C. Capelozzi V.L. Takagaki T.Y. Younes R.N. Yagi N. Saldiva P.H.N. Morphometric evaluation of argyrophilic organiser regions is useful in predicting long-term survival in squamous cell carcinoma of the lung Chest 111 1997 110-114
3. Antonangelo L. Saldiva P.H.N. Amaro E. Jr. Capelozzi V.L. Utility of computerized morphometry combined with AgNOR staining in distinguishing benign from malignant pleural effusions Anal. Quant. Cytol. Histol. 16 1994 247-252
4. Baak J.P.A. Hermans V.D. Kurver P.H.J. Hermans J. The value of morphometry to classic prognosticators in the breast cancer Cancer 56 1985 374-382
5. Bernardi F.D.C. Capelozzi V.L. Takagaki T. Younes R. Saldiva P.H.N. Usefulness of morphometric evaluation of histopathological slides is useful in predicting long-term outcome of patients with squamous cell carcinoma of the lung, A preliminary report Chest 107 1995 614-620
6. Carvalho H.A. Takagaki T.H. Saldiva P.H.N. Capelozzi V.L. Stereological estimates of nucleus/cytoplasm ratio and star volume on fiberoptic biopsies are of prognostic value to discriminate survival after radiotherapy in advanced squamous cell carcinoma of the lung Histopathology 31 1997 420-429
7. Carvalho P.E.O. Antonângelo L. Bernardi F.D.C. Leão L.E.V. Rodrigues O.R.R. Capelozzi V.L. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas Jpn. J. Clin. Oncol. 30 11 2000 478-486
8. Cemeriki c-Martinovi V. Tripnac D. Ercegovac M. Correlations between mitotic and apoptotic indices, number of interfases NORs and histologic grading in squamous cell lung cancer Microsc. Res. Technol. 40 1998 408-417
9. Crissman J.D. Liu W.Y. Gluckman J.L. Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx Cancer 54 1984 2995-3001
10. D'Amico T.A. Massey M. Herndon .J.E. Moore M.-B. Harpole D.H. Abiologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of tem molecular markers J. Thorac. Cardiovasc. Surg. 117 1999 736-743
11. Demarchi L.M.M. Reis M.M. Palomino S.A.P. Farhat C. Takagaki T. Beyruti R. Saldiva P.H.N. Capelozzi V.L. Prognostic values of stromal density and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung Mod. Pathol. 13 2000 511-520
12. Elison D.J. Nathvani B.W. Metter G.E. Tuner R.R. Mitotic count in follicular lymphomas Hum. Pathol. 18 1987 502-505
13. Gundersen H.J.G. Bendtsen T.F. Korbo L. Marcussen N. Muller A. Nielsen K. et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis APMIS 96 1988 379-394
14. Harpole D.H. Jr. Herndon J.E. Wolfe W.G. Iglehart J.D. Marks J.R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression Cancer Res. 55 1993 51-56
15. Harpole D.H. Jr. Richards W.G. Herndon J.E. II Sugarbaker D.J. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer Ann. Thorac. Surg. 61 1996 1470-1476
16. Ishida T. Kaneko S. Akazawa K. Tateishi M. Sugimachi Z. Sugio K. Proliferating cell nuclear antigen expression and argyrophilic nuclear organiser regions (AgNOR) as factor influencing prognosis of surgically treated lung cancer patients Cancer Res. 53 1993 5000-5003
17. Kaneko S. Sugimachi Z. Ishida T. Sugio K. Yokoyama H. Nucleolar organizer regions as a prognostic indicator for stage I non-small cell lung cancer Cancer Res. 51 1991 4008-4011
18. Lee T.-K. Horner D.R. Silverman J.F. Chen Y.-H. Jenny C. Scarantino C.W. Morphometric and morphologic evaluations in stage III non-small cell lung cancers Cancer 63 1989 309-316
19. Lee T.-K. Myers R.T. Bond G. Marshall R.B. Kardon B. The significance of mitotic rate: a retrospective study of 127 thyroid carcinomas Hum. Pathol. 16 1985 1042-1046
20. Lee T.-K. Myers R.T. Bond G. Marshall R.B. Kardon B. The significance of nuclear diameter in the biologic behaviour of thyroid carcinomas: a retrospective study of 127 cases Hum. Pathol. 12 1987 1252-1256
21. Liotta L.A. Tumor invasion and metastases - Role of the extracellular matrix: rhoads memorial award lecture Cancer Res. 46 1986 1-7
22. Martinez C. Miroff G. Bittner J.J. Effect of size and/or rate of growth of a transplantable mouse adenocarcinoma on lung metastasis production Cancer Res. 16 1956 313
23. Miller J.R. Milton G.W. Mitotic counts of metastatic carcinoma in the spleen and liver J. Pathol. Bacteriol. 85 1963 237
24. Mountain C.F. Revisions in the international system for staging lung cancer Chest 111 1997 1710-1717
25. Oyama T. Mitsudomi T. Yoshida Y. Mizoue T. Hamada T. Shira K.T. Nuclear organizer regions are independently associated with a shortened survival in patients with non-small cell lung cancer Surg. Oncol. 2 1993 341-347
26. Ploton D. Menager M. Jeannesson P. Himber G. Pigeon F. Adnett J.J. Improvement in the staining and in the visualization of argyrophilic proteins of nucleolar organizer regions at the optical level Histochem. J. 18 1986 5-14
27. Rodrigues O. Antonangelo L. Capelozzi V.L. Yagi N. Schimidt A.F. Goldemberg S. Prognostic significance of argyrophilic nucleolar organizer region (AgNOR) in resected non-small cell lung cancer (NSCLC) Jpn. J. Clin. Oncol. 27 1997 298-304
28. Sorensen J.B. Olsen J.E. Prognostic implications of histopathologic subtyping in patients with surgically treated stage I or II adenocarcinoma of the lung J. Thorac. Cardiovasc. Surg. 97 1989 245-251
29. Takahashi M. An experimental study of metastases J. Pathol. Bacteriol. 20 1915 1
30. Travis W. Colby T. Corrin B. Shimosato Y. Brambilla E. Histological typing of lung and pleural tumours, WHO, World Health Organization, International Histological Classification of Tumours 3rd Edition 1999 Springer Berlin/Heidelberg
31. Tubian M. Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival Radiother. Oncol. 15 1989 1-18
32. Van Bogaert L.-J. De Muylder C. Maldague P. Maisin H. Prognostic implications of mean nuclear diameter in breast cancer Br. J. Cancer. 42 1980 537-541
33. Weiss W. Boucot K.R. Cooper D.A. The survival of men with measurable proved lung cancer in relation to growth rate Am. J. Roentgen. 98 1966 404
34. Weiss W. Boucot K.R. Cooper D.A. Growth rate in the detection and prognosis of bronchogenic carcinoma JAMA 198 1966 1246
35. Willis R.A. Mitoses in the hepatic metastases of malignant tumors J. Pathol. Bacteriol. 35 1932 11